Title : Dihydromyricetin Attenuates Inflammation through TLR4/NF-kappaB Pathway.

Pub. Date : 2019

PMID : 31572805






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The present study showed that DHM treatment alleviated LPS-induced viability reduction, suppressed the mRNA levels of IL-6, IL-1beta and TNF-alpha, inhibited the mRNA and protein expression of iNOS and COX-2, and attenuated the activation of NF-kB and TLR4 signaling in a concentration-dependent manner. dihydromyricetin interleukin 6 Mus musculus